Effect of spearmint -ginger capsule on nausea and vomiting
Phase 1
Recruiting
- Conditions
- Breast cancer patients.
- Registration Number
- IRCT20180215038741N1
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
History of at least one course of chemotherapy
History of nausea and vomiting after previous chemotherapy sessions
Definitive diagnosis of breast cancer by clinical trials and an oncologist
Exclusion Criteria
Having a history of allergy to ginger or mint and taking them over the past week
Having other nausea-causing problems such as high blood pressure, liver failure, kidney problems and digestive problems
Metastasis to other organs of other body systems
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of nausea, Severity of nausea, Incidence of vomiting. Timepoint: An hour before chemotherapy, during chemotherapy, first, second, third, fourth and fifth days of chemotherapy. Method of measurement: A questionnaire, an information recording form, and a standard analogue visual analogue tool.
- Secondary Outcome Measures
Name Time Method . Timepoint: . Method of measurement: .